down arrow

Nuvalent, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6707031075
USD
106.86
1.9 (1.81%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

104.95108.04

52 Week

55.53112.84
Valuation
Technical
Day's Volume

CASH

423.05 k

Shareholding (Mar 2025)

FII

9.92%

Held by 110 FIIs

DII

25.84%

Held by 42 DIIs

Promoter

29.62%

How big is Nuvalent, Inc.?

22-Jun-2025

As of Jun 18, Nuvalent, Inc. has a market capitalization of 5,461.77 million, with total assets of 1,141.75 million and shareholder's funds of 1,069.79 million. The company reported net sales of 0.00 million and a net profit of -300.85 million over the latest four quarters.

Market Cap: As of Jun 18, Nuvalent, Inc. has a market capitalization of 5,461.77 million, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the sum of Net Sales is 0.00 million, while the sum of Net Profit is -300.85 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, Shareholder's Funds amount to 1,069.79 million, and Total Assets are reported at 1,141.75 million.

Read More

What does Nuvalent, Inc. do?

22-Jun-2025

Nuvalent, Inc. is a mid-cap pharmaceutical and biotechnology company with a market cap of approximately $5.46 billion. As of March 2025, it reported a net profit loss of $85 million and has no dividend yield.

Overview: <BR>Nuvalent, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a mid-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -85 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 5,461.77 Million (Mid Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.06 <BR>Return on Equity: -27.84% <BR>Price to Book: 5.40<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Is Nuvalent, Inc. technically bullish or bearish?

20-Sep-2025

As of September 11, 2025, Nuvalent, Inc. shows a bullish trend in the short term, despite mixed signals in longer time frames and a significant underperformance compared to the S&P 500 over the past year.

As of 11 September 2025, the technical trend for Nuvalent, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the monthly MACD and Dow Theory show mildly bearish signals, suggesting some caution. The stock has underperformed the S&P 500 over the past year with a return of -21.11% compared to the S&P's 17.14%, but it has significantly outperformed over the last three years with a return of 357.92% versus 70.41% for the benchmark. Overall, the current technical stance is bullish, but the mixed signals in longer time frames indicate a moderate strength.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 5,756 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.07

stock-summary
Return on Equity

-33.83%

stock-summary
Price to Book

6.13

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-100 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
34.35%
0%
34.35%
6 Months
36.68%
0%
36.68%
1 Year
12.78%
0%
12.78%
2 Years
61.42%
0%
61.42%
3 Years
196.59%
0%
196.59%
4 Years
435.1%
0%
435.1%
5 Years
0%
0%
0.0%

Nuvalent, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Nuvalent, Inc. technically bullish or bearish?

As of 11 September 2025, the technical trend for Nuvalent, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the monthly MACD and Dow Theory show mildly bearish signals, suggesting some caution. The stock has underperformed the S&P 500 over the past year with a return of -21.11% compared to the S&P's 17.14%, but it has significantly outperformed over the last three years with a return of 357.92% versus 70.41% for the benchmark. Overall, the current technical stance is bullish, but the mixed signals in longer time frames indicate a moderate strength....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-308.02%
EBIT to Interest (avg)
-131.72
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.06
Sales to Capital Employed (avg)
0
Tax Ratio
0.18%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.54
EV to EBIT
-14.04
EV to EBITDA
-14.04
EV to Capital Employed
-72.86
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-27.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 64 Schemes (34.62%)

Foreign Institutions

Held by 110 Foreign Institutions (9.92%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -74.30% vs -96.56% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-104.60",
          "val2": "-65.20",
          "chgp": "-60.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-99.70",
          "val2": "-57.20",
          "chgp": "-74.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -106.66% vs -54.09% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-280.40",
          "val2": "-149.50",
          "chgp": "-87.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-17.90",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-260.80",
          "val2": "-126.20",
          "chgp": "-106.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-104.60
-65.20
-60.43%
Interest
0.00
0.00
Exceptional Items
-6.00
0.00
Consolidate Net Profit
-99.70
-57.20
-74.30%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -74.30% vs -96.56% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-280.40
-149.50
-87.56%
Interest
0.00
0.00
Exceptional Items
-17.90
0.00
Consolidate Net Profit
-260.80
-126.20
-106.66%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -106.66% vs -54.09% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Nuvalent, Inc. stock-summary
stock-summary
Nuvalent, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."